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Background: Errors in medication use are a patient safety concern globally, with different regions report-
ing differing error rates, causes of errors and proposed solutions. The objectives of this review were to
identify, summarise, review and evaluate published studies on medication errors, drug related problems
and adverse drug events in the Gulf Cooperation Council (GCC) countries.
Methods: A systematic review was carried out using six databases, searching for literature published
between January 1990 and August 2016. Research articles focussing on medication errors, drug related
problems or adverse drug events within different healthcare settings in the GCC were included.
Results: Of 2094 records screened, 54 studies met our inclusion criteria. Kuwait was the only GCC country
with no studies included. Prescribing errors were reported to be as high as 91% of a sample of primary
care prescriptions analysed in one study. Of drug-related admissions evaluated in the emergency depart-
ment the most common reason was patient non-compliance. In the inpatient care setting, a study of
review of patient charts and medication orders identified prescribing errors in 7% of medication orders,
another reported prescribing errors present in 56% of medication orders. The majority of drug related
problems identified in inpatient paediatric wards were judged to be preventable. Adverse drug events
were reported to occur in 8.5–16.9 per 100 admissions with up to 30% judged preventable, with occur-
rence being highest in the intensive care unit. Dosing errors were common in inpatient, outpatient and
primary care settings. Omission of the administered dose as well as omission of prescribed medication
at medication reconciliation were common. Studies of pharmacists’ interventions in clinical practice
reported a varying level of acceptance, ranging from 53% to 98% of pharmacists’ recommendations.
Conclusions: Studies of medication errors, drug related problems and adverse drug events are increasing
in the GCC. However, variation in methods, definitions and denominators preclude calculation of an over-
all error rate. Research with more robust methodologies and longer follow up periods is now required.
 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
The use of medication is perhaps the most common interven-
tion in medical practice. Medication use occurs in many different
settings and involves different health care practitioners, as well
as patients and their carers (Franklin and Tully, 2016). There are
different types of problems associated with medication use, some
are preventable events, some are not, and some result in injurytings in
2 J. Alsaidan et al. / Saudi Pharmaceutical Journal xxx (2018) xxx–xxxand some do not. Medication errors (ME), are a global health care
concern with the majority of research published from developed
countries such as the United States of America and Europe
(Morimoto et al., 2010) and (Jha et al., 2010) and much less infor-
mation on the incidence and types of errors within the Middle East
and the GCC in particular.
The GCC comprises six countries: Bahrain, Kuwait, Oman, Qatar,
Saudi Arabia, and United Arab Emirates (UAE). These countries are
listed by the United Nations World Bank as high income countries
(World Bank, 2017). Total expenditure on health as a percentage of
the country’s gross domestic product ranged from 2.2% to 5% in
2014 (World Health Organization, 2014). The GCC countries’ health
systems are also comparable and are more similar to each other
than to other countries within the Eastern Mediterranean Region
or other Middle Eastern countries.
A previous systematic review of MEs across the whole of the
Middle East concluded that ‘the main factor contributing to MEs
[. . .] is poor knowledge of medicines by both doctors (prescribers)
and nurses (administering drugs).’ (Alsulami et al., 2013). Publica-
tions specifically from the GCC region report ME as an issue within
both primary care and the inpatient setting (Al Khaja et al., 2005;
Al Khaja et al., 2007; Al-Dhawailie, 2011). However, ME terminol-
ogy used among the studies is different, as are the different types
of medication safety aspects studied. The concept of ‘‘medication
safety” potentially encompasses a wide range of areas (Ackroyd-
Stolarz et al., 2006; McLeod, 2016). We therefore aimed to conduct
an updated systematic review of medication safety research from
the GCC countries in order to describe the breadth of problems
associated with medication use. This will enable a more complete
representation of what has been explored in this region regarding
medication errors and helps identify gaps in the literature and
focusses on preventable harm relating to medication use in clinical
practice. Our objectives were to summarise and evaluate quantita-
tive as well as qualitative evidence published on MEs, drug related
problems (DRPs) and adverse drug events (ADEs) within the GCC
region and to make recommendations for addressing any gaps in
the literature identified.2. Methods
2.1. Data sources and search strategy
The following electronic databases were searched for the period
1 January 1990 to 31 August 2016: CINAHL Plus, EMBASE, Interna-
tional Pharmaceutical Abstracts, PubMed (MEDLINE), ScienceDir-
ect, and Web of Science. Bibliographies of relevant publications
were also hand searched.
The search strategy was tailored to each database and medical
search headings (MeSH terms) were also utilised for PubMed
(MEDLINE). One author (JAS) screened the titles and abstracts of
all 3115 records identified, for relevance and to determine if the
complete text should be retrieved for comparing against inclu-
sion/exclusion criteria and potential inclusion to the review. A ran-
dom 10% sample was then screened by a second reviewer NAS to
assess reliability. Cohen’s kappa (K) value (Cohen, 1960) was calcu-
lated to be 0.568; according to Landis and Koch (1977) this is inter-
preted as indicating moderate agreement. Any differences in
opinion about the relevance of the papers were resolved by discus-
sion. For final study selection, the full text was assessed by JAS; any
uncertainty was referred to NAS. Any cases of disagreement were
referred to BDF, with further clarification and consultation under-
taken by JP and HA as needed. Details of the protocol were regis-
tered with the PROSPERO international prospective register of
systematic reviews (reference CRD42016038733).Please cite this article in press as: Alsaidan, J., et al. Systematic review of the sa
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2.2.1. Inclusion criteria
Research articles focussing on medication errors in the GCC
countries published in English or Arabic were included. Both qual-
itative and quantitative studies of all study designs were included.
Relevant conference abstracts were also included given the antici-
pated paucity of published full text research articles within the
GCC. Studies on prescribing, dispensing, administration and moni-
toring errors in inpatient, hospital outpatient and primary care set-
tings whether hospital or community pharmacies were included.
Also included for review were studies examining administration
errors by patients/caregivers in their own homes as well as original
descriptive research on medication reconciliation errors and med-
ication history errors (errors in the process of documenting the
medications the patient is taking or used to take). According to
the definitions utilised by the Saudi Arabian Ministry of Health
the term ME was defined as: ‘‘Any preventable event that may cause
or lead to inappropriate use or patient harm while the medication is in
the control of the health care professional, patient or consumer”
(Saudi Arabian Ministry of Health, 2012). Studies assessing DRPs
and ADEs, (both preventable and non-preventable) potentially
inappropriate medications (PIMs) were also included. Lastly, stud-
ies of pharmacists’ interventions to reduce MEs, ADEs or DRPs were
also reviewed for inclusion. Studies meeting the review inclusion
criteria were included in the analysis.
2.2.2. Exclusion criteria
Letters, opinion pieces, editorials and case reports were
excluded. Studies focussing on expected side effects occurring with
the proper use of a medication were also excluded, where a side
effect was defined as: ‘‘An expected, well known reaction that results
in little or no change in patient management”(Ninno and Ninno,
2000). Research concerned with blood/blood products, parenteral
and enteral nutrition was excluded. Systematic reviews that had
studies involving the GCC countries among their review of studies
were not included in the review but used as a potential source to
identify further relevant studies for inclusion. Finally, articles asso-
ciated with attitudes, perceptions, or views on clinical services
were excluded.
2.2.3. Process of data extraction
Search results were exported to Endnote X7 (Thomson Reuters,
Times Square New York, NY, USA).
Duplicates were removed. Article titles and abstracts were ini-
tially screened for relevance to the systematic review inclusion
and exclusion criteria, followed by full text retrieval analysis.
Any ambiguities were discussed with BDF and NAS. Further clarifi-
cation and consultation was undertaken by JP and HA if needed.
Data from included studies was extracted on to a data collection
sheet developed for this purpose. The extracted data comprised
of country, setting and data collection duration, study design, def-
initions used for study outcomes, the medication safety aspect
analysed method of error identification, and reported results. The
extraction form was completed by JAS and reviewed by NAS and
BDF. Any discrepancies were resolved by discussion with the
remaining authors.
2.2.4. Quality assessment
Quality assessment of the reviewed included studies was car-
ried out by JAS and NAS with any remaining uncertainties directed
to and resolved by BDF. The quality assessment was carried out as
part of the analysis of the included studies; study quality was
based on specific aspects relating to medication safety researchfety of medication use in inpatient, outpatient and primary care settings in
https://doi.org/10.1016/j.jsps.2018.05.008
J. Alsaidan et al. / Saudi Pharmaceutical Journal xxx (2018) xxx–xxx 3(e.g. methods used for identifying medication errors). The studies
were therefore reviewed according to 15 criteria (Appendix B)
adapted from previous studies (Allan and Barker, 1990; Ghaleb
et al., 2006; Alsulaimi et al., 2013; McLeod et al., 2013). The first
thirteen criteria are relevant to all medication error study types,
while the remaining two apply only to studies of administration
error. Any criteria not applicable to the study design were classi-
fied as ‘not applicable’ For the purpose of this study it was decided
to assess the quality of the conference abstracts by adapting same
criteria as for full text articles, as there are no is universally
accepted criteria to evaluate conference abstracts.3. Results
3.1. Search results
The search yielded a total of 3115 hits; an additional two were
identified via search of bibliographies to give a total of 3117. After
duplicate removal, the number of records remaining was 2094. All
studies identified were in English, no studies in Arabic were iden-
tified. Following initial screening, 294 records were assessed as
being potentially relevant. Following full text screening, 54 studies
were identified for inclusion: 42 full papers and 12 conference
abstracts (Fig. 1).Id
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the majority of the studies were carried out in Saudi Arabia. None
of the included studies were conducted in Kuwait.
3.2. Quality assessment
Quality of the studies varied (Appendix B). Many studies did not
specify a definition for ME, and/or the categories of ME included.
Criteria 14 and 15 were only applicable to three studies, one
abstract by Aljamal (2012) and two full text studies, by Almazrou
et al. (2015) and by Sadat-Ali et al. (2010). Most studies adequately
described the setting and study objectives. Only six of the 54 stud-
ies adequately described sample size calculations. The majority of
the conference abstracts did not meet quality assessment criteria
such as the inclusion of sample size calculations, validity and reli-
ability, study limitations or details of ethical approval, most likely
due to their limited word count.
3.3. Description of included studies
Studies were classified within five main categories, with studies
of ME further categorised into six subcategories (Fig. 3).
The following is a summary of the characteristics of the
included studies; more details are given in Appendix D. It was) 
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(Al Khaja et al., 2006; Alanazi et al., 2015) and drug classes used
inappropriately were benzodiazepines and tri-cyclic antidepres-
sants (Al Omar et al., 2013).
3.3.1. Studies describing medication errors
3.3.1.1. Studies describing prescribing errors. Seventeen studies
described prescribing errors. Seven were cross-sectional audits of
prescriptions (Al Khaja et al., 2005; 2006; 2007; 2008; Khoja et
al., 2011; Al-Hussein, 2008; Albarrak et al., 2014); all studied hand-
written prescriptions except for Albarrak et al. (2014) who
included both handwritten and electronic prescriptions. Five were
retrospective audits (Al Khaja et al., 2012; Altebenaui et al., 2015;
Al Shahaibi et al., 2012; Irshaid et al. 2005; Aseeri 2013), as well as
three retrospective analyses of patient charts (Mahmoud et al.
2016; Aljeraisy et al. 2011; Youssef et al. 2015) and two cross-
sectional chart reviews (Alanazi et al. 2015; Al-Dhawailie, 2011).
Data collection periods ranged from two weeks to three years.
Common prescribing error definitions were those of Dean et al.
(2000) and Neville et al. (1989). Appendix C gives more informa-
tion on the definitions.
Ten studies were conducted within a primary care or outpatient
care setting while the remaining four related to the hospital set-
ting. Two studies assessed prescriptions from inpatient and outpa-
tient setting. Within outpatient and primary care settings, the
prevalence and types of prescribing errors have been described
for infants as well as adults. In a study analysing prescriptions
issued for infants (Al Khaja et al., 2007) approximately 91% of pre-
scriptions contained an error. In another study by Al Khaja et al.
(2006), approximately one fifth of infants were prescribed antibi-
otics at subtherapeutic doses. For adults, studies report varying
results, ranging from approximately 7% as reported by Al Khaja
et al. (2005), to 18% of prescriptions containing errors (Khoja
et al. 2011). Al Khaja et al. (2012) revealed approximately one
quarter of prescriptions ordered by two-thirds of primary care
physicians had errors. Other studies reported up to 50% of prescrip-
tions missing at least one item of information (Altebenaui et al.
2015). Furthermore up to 88% of prescriptions written by junior
doctors were identified to contain major errors of omission and
commission or errors of integration (Al Khaja et al., 2008). Errors
of integration or knowledge-based errors in prescribing were
defined in the study to include potential drug-drug interactions
or drug allergies, which may reflect a failure of the prescriber toPlease cite this article in press as: Alsaidan, J., et al. Systematic review of the sa
the Gulf Cooperation Council countries. Saudi Pharmaceutical Journal (2018),integrate information about the patient or drug history (Al Khaja
et al., 2008). An Omani study by Al Shahaibi et al. (2012) found that
different kinds of omission error were evident in up to 72% of pre-
scriptions. While Irshaid et al. (2005) reported, from their analysis
of prescriptions, that physicians’ handwriting was illegible in
approximately 64% of prescriptions. In 2015, Alanazi, Aljeraisy,
Salam reported that the prevalence of inappropriate antibiotic pre-
scriptions with at least one or more types of error was significantly
higher among paediatric patients compared to adult patients. In
2008 Al-Hussein carried out a study in which prescriptions were
checked for compliance with 14 components of local guidelines;
87% of prescriptions did not meet these requirements (Al-
Hussein, 2008).
Regarding prescribing errors within an inpatient setting, follow-
ing analysis of inpatient handwritten medication charts and med-
ication orders, Mahmoud et al. (2016), reported that the incidence
of prescribing errors was 3.6 (95% CI, 3.3–3.9) per 100 prescrip-
tions, 33.9 (95% CI, 31.5–36.6) per 100 admissions and 76.5 (95%
CI, 70.9–82.3) per 1000 patient days. Al-Dhawailie (2011) reported
approximately 7% of medication orders had prescribing errors.
Aljeraisy et al. (2011) reported that in a tertiary paediatric inpa-
tient setting in Saudi Arabia, the overall error rate was 56 per
100 medication orders (95% CI: 54.2%, 57.8%). Dosing errors were
most prevalent error type in all three studies. In a Saudi Arabian
study by Youssef et al., (2015) on types of contraindicated medica-
tions, approximately 14% of the contraindicated medications that
resulted in a computerised prescribing system alert were still
administered to patients with renal insufficiency by the ordering
physician.
Two studies assessed prescribing errors from more than one
hospital area. In 2014 Albarrak et al. compared handwritten and
electronic prescriptions in primary care and outpatient surgery set-
ting and inpatient respectively, for legibility, completeness and
medication errors. A statistically significant difference was identi-
fied (P < 0.001) between handwritten and e-prescriptions in omit-
ted dose and omitted routes of administration. One study
described the use of a tool to decrease problems associated with
medication use, retrospectively reviewing prescriptions from out-
patient, inpatient and emergency department settings (Aseeri,
2013). This study reported the outcome of introducing an antibi-
otic dosing standardisation policy and its reduction of prescribing
errors. Physicians were vigilant in documenting patient weight
on prescriptions after the implementation of standardized dosingfety of medication use in inpatient, outpatient and primary care settings in
https://doi.org/10.1016/j.jsps.2018.05.008
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approximately 34% of prescriptions pre-implementation phase to
approximately 5% of prescriptions analysed after the implementa-
tion phase, a statistically significant reduction.
3.3.1.2. Studies describing administration errors. Two studies were
identified, both observational in nature, where observation of med-
ication administration was the method of data collection. One was
carried out in an outpatient pharmacy waiting area, and the other
in the inpatient setting. In the outpatient setting, Almazrou et al.
(2015), revealed that 58% of mothers (patient carers’) measured
an accurate dose of paracetamol using an oral syringe versus 50%
of mothers using a dropper and 51% using a dosing cup. Dosing
accuracy for each type of instrument was influenced by the
mothers’ education status.
Aljamal (2012) observed nurses during medication administra-
tion in the inpatient setting. A total of 169 medication administra-Please cite this article in press as: Alsaidan, J., et al. Systematic review of the sa
the Gulf Cooperation Council countries. Saudi Pharmaceutical Journal (2018), htion errors were observed of 2112 opportunities for error,
representing an error rate of 8%. The most common errors were
wrong time, dose omission, and wrong dose.
3.3.1.3. Studies assessing errors in medication history and medication
reconciliation errors. There were several methods used by the five
studies of medication reconciliation or medication history errors.
Pharmacists screened the patient chart and performed interviews
to identify discrepancies at admission or at discharge, triage or
transfer between inpatient wards; and then compared with patient
medical record or patient discharge medication list (Abu Yassin
et al. 2011, Aljadhey and Al-Rashoud 2013, Al Anany et al., 2012;
Rehmani 2011). Another study developed a medication reconciliation
(MR) form as a tool to detect medication discrepancies (Sonallah
et al. 2014). Discrepancies found in patients medication lists at
triage, admission or discharge ranged from 18% up to
approximately 77% of patient cases interviewed (Aljadhey andfety of medication use in inpatient, outpatient and primary care settings in
ttps://doi.org/10.1016/j.jsps.2018.05.008
6 J. Alsaidan et al. / Saudi Pharmaceutical Journal xxx (2018) xxx–xxxAl-Rashoud, 2013) and Sonallah et al., (2014). The most common
types of unintended medication discrepancies were medication
omissions, followed by errors in dosages.
3.3.1.4. Studies assessing potentially inappropriate medications (PIM)
use. Two studies, both from Saudi Arabia, assessed PIMs in elderly.
Al-Omar et al. (2013) reported that approximately 44% of the
patients had filled a prescription for at least one PIM in the outpa-
tient setting, and Al Odhayani et al. (2016) reported that approxi-
mately 53% of the elderly participants attending appointments in
the outpatient clinics or as part of home health care programme
were using one or more PIMs. Harm caused by these PIMs was
not assessed.
3.3.1.5. Studies assessing more than one type of medication
error. ‘Overall, eight studies reported more than one type of med-
ication error. Two studies were retrospective in designs. The first, a
retrospective study by Dibbi et al. (2006) reviewed medical records
for adult hospitalised patients for 2 years and reported that the
most common type of error was wrong strength (concentration).
The second, a retrospective study by Alakhali et al. (2014) reviewed
prescriptions from the outpatient setting for two months and
identified 1850 opportunities for error and 201 (10.9%) prescribing,
dispensing and administration errors.
Five studies assessed more than one type of medication errors
using incident reports. The following studies all took place in large
tertiary care hospitals in Saudi Arabia. Incidents were reported at
a rate of 5.8 per 1000 patient days as stated by Arabi et al. (2012).
Medication errors made up approximately 7% of all incident reports
from the hospital and approximately 13% of all incident reports
from the ICU. In a study by Alshaikh et al. (2013), the medication
error rate over the 1-year study period was 0.4% (949 medication
errors for 240,000 prescriptions), approximately 2% of the medica-
tion errors were categorised as resulting in any harm to the patient.
Medication errors were reported to have originated predominantly
at the prescribing stage of themedication process. In the third study,
all medication error incident reports collected in the two year per-
iod were analysed (Sadat-Ali et al., 2010), and 38 medication errors
reported from 23,597 admissions, giving a medication error report-
ing rate of 0.15% per admission. The fourth study was specific to a
neonatal intensive care unit (Hemida et al., 2011), estimating an
incidence of one report involving medication error per 250 admis-
sions, with antibiotics most commonly involved. The last study
(Al-Khani et al., 2014) determined 10% of prescribing errors
included in the hospital reporting system were identified by phar-
macists to be prescribing errors involving the wrong drug.
The remaining study by Elnour et al. (2007) reported the impact
of the structured educational programme for inpatient nursing
staff on the usage of MedSafe tool, a medication error reporting
program launched in all inpatient nursing stations. Results indi-
cated an increase in the number of ME reported to the Med Safe
Tool after the structured program, the types of errors most often
reported were monitoring errors and dosage errors.
3.3.2. Studies of DRPs
Five studies assessed DRPs. All five differentiated preventable
and non-preventable DRPs. The DRP definition and classification
of the Pharmaceutical Care Network in Europe (PCNE 2006, and
2010) was used by two studies (Rashed et al., 2012; Al Hamid
et al., 2016). Three studies (Al-Olah and Al Thiab, 2008, Al-Arifi,
2014; Alghamdy et al. 2015) defined DRPs according to the
definition of Strand et al. (1990). The different DRP categories iden-
tified across all five studies included adverse reactions, drug choice
problems, dosing problems, and interactions. Pharmacists’ clinical
interventions on identification of DRPs were at the prescriber level,
patient/caregiver level, and the drug level.Please cite this article in press as: Alsaidan, J., et al. Systematic review of the sa
the Gulf Cooperation Council countries. Saudi Pharmaceutical Journal (2018),Al-Olah and Al Thiab (2008) reported that the most common
definite DRP-related admission to hospital was due to failure to
receive medications accounting for approximately 47% of all DRPs,
followed by adverse drug reactions approximately 25% of all iden-
tified DRPs respectively. Al-Arifi, 2014 reported approximately 19%
of patients presented to the emergency department due to DRPs
and approximately 93% of these patients needed hospital admis-
sion. The most common DRPs were adverse drug reactions (ADRs)
and patients’ non-adherence. Alghamdy et al. (2015) reported
approximately 5% of admissions were due to DRPs, 70% of which
were preventable. Rashed et al. (2012) assessed attendance of pae-
diatric patients to the emergency department and DRP incidence
was reported as approximately 29%; the majority were judged pre-
ventable. Al Hamid et al. (2016), randomly selected 150 patient
medical records from all admissions for patients over 18 years of
age and identified 94 MRPs, of which 67% were definite (actual as
defined by PCNE 2010, based on personal communication Alhamid,
October 2017), while 33% were probable (potential as defined by
PCNE 2010). Major risk factors associated with MRPs were
polypharmacy and patient non-adherence.
3.3.3. Studies assessing adverse drug events
Three studies assessed ADE. A study from UAE, by Al-Tajir and
Kelly (2005), compared two methods to detect ADEs. The first
method of data collection for ADEs was limited to spontaneous
reporting. For the second arm of the study active monitoring for
ADEs took place. It was concluded that the incidence of ADEs
detected through surveillance (active monitoring) was signifi-
cantly higher than for ADEs reported spontaneously for both inpa-
tients and outpatients. About 56% of ADEs identified by both
methods combined were judged definite or probable and, of these,
approximately 14% were consistently judged preventable.
In Saudi Arabia, Aljadhey et al. (2013) determined the incidence
of in-hospital ADEs and assessed their severity and preventability
in an academic tertiary hospital. Incidents were identified through
a combination of medical record review by study pharmacists and
voluntary reports from other health care professionals. The inci-
dence of ADEs was 8.5 per 100 admissions. Incidences of pre-
ventable and non-preventable ADEs were 2.6 and 6 per 100
admissions respectively. In a more recent study, Aljadhey et al.
(2016) determined the incidence of in-hospital ADEs and assessed
their severity and preventability in four hospitals in Saudi Arabia.
Incidents were identified as described in the study above
(Aljadhey et al. 2013). Authors used a variety of ages to differenti-
ate adults from children. The incidence of ADEs per 100 admissions
was 6.1 and the incidence of potential ADEs was 16.9 per 100
admissions where a potential ADE was defined as an error that car-
ried a risk of causing injury related to the use of a medication but
harm did not occur, either because of specific circumstances or
because the error was intercepted (Morimoto et al. 2004).
3.3.4. Studies of pharmacists’ interventions
Nine studies focused on pharmacists’ interventions, these had a
variety of designs and interventions were aimed to address assess-
ment/reduction of medication errors or problems associated with
medication use. The interventions included pharmacists’ docu-
mentation of interventions on prescriptions on the inpatient ward,
or in primary care clinics; pharmacist performing medication use
reviews pharmacist counselling to patients, pharmacist education
to physicians. The first was a conference abstract (Rahman et al.,
1994) in which authors documented interventions on prescriptions
with an intervention rate (error rate) was 1.3%. Al-Rashdi et al.
(2010), Al Rahbi et al., (2014) both studies from Oman. Hooper
et al. (2009), was a study from Qatar. These three studies
documented pharmacists’ interventions on prescriptions and
reported rates of interventions acceptance ranging from 53% upfety of medication use in inpatient, outpatient and primary care settings in
https://doi.org/10.1016/j.jsps.2018.05.008
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et al. (2012), reported benefits of comprehensive pharmacist coun-
selling. There was a significant difference in the occurrence of ADEs
between the control group (no pharmacist counselling) and inter-
vention group. In the control group, 61% of ADEs were judged pre-
ventable, and 39% were judged to be serious. Al-Jazairi et al. (2008)
studied the participation of a clinical pharmacist in an ICU setting,
reporting that the medical team accepted approximately 95% of the
interventions. The main DRPs were: no drug prescribed for the
medical condition, inappropriate dosing regimen and no indication
for drug use. Mitwally et al. (2015) in Qatar reported a 52% reduc-
tion in prescribing errors after the prescribing physicians attended
educational sessions prepared by the clinical pharmacy team.
Rashed et al. (2012) investigated DRPs in hospitalised children
and 258 DRP were identified for 186 children. The median number
of DRPs per patient was one. Dosing problems were the most com-
mon, followed by drug choice problems and ADRs. Regarding the
interventions, approximately 43% of all interventions were at drug
level, approximately 40% of interventions at prescriber level and
approximately 10% of interventions were done at patient/caregiver
level. Kheir et al. (2014) reported the results of their exploratory
study of conducting interviews as part of medication use reviews
within a primary health care facility in Qatar. The most commonly
encountered DRPs were non-adherence and adverse drug
reactions.
3.3.5. Studies on perceptions of health care practitioners towards
medication errors
Three studies considered this topic; all were conducted in Saudi
Arabia. Al-Rowibah et al. (2013) reported the findings on the
impact of computerised physician order entry (CPOE): 72% of
physicians agreed that CPOE helped them to decrease ADEs, but
55% reported that it created new types of errors. Al-Arifi, 2014
reported the results of a validated questionnaire to community
pharmacists on dispensing errors. The majority of respondents
indicated that the risk of dispensing errors was increasing and
most of them were aware of dispensing errors. Al Anazi and Al-
Jeraisy (2015) used a survey to collect information on healthcare
professionals’ perceptions towards contributing factors of medica-
tion error (ME) occurrence. Some of the underlying factors of MEs
reported were interruptions while writing the order, lack of clarity
of physicians order, and no double-checking of the doses.
4. Discussion
4.1. Key findings
Fifty-four studies were identified that met our inclusion criteria;
the majority were conducted in Saudi Arabia. No articles from
Kuwait met inclusion criteria while only two were from the UAE.
Notably, Kuwait is the only one of the six that is not a member of
the Uppsala Monitoring Centre which is part of the WHO Pro-
gramme for International Drug Monitoring (WHO Collaborating
Centre for International Drug Monitoring, 2017). Saudi Arabia is
the largest and has the highest population of the GCC countries, all
of which are factors thatmay account for the larger number of stud-
ies from this country. None of the included studies had a qualitative
study design, and it may therefore be important to supplement
quantitative studies with qualitative research to help understand-
ing of the causes of medication errors and other problems, as well
as identifying barriers and facilitators to addressing them.
4.2. Interpretation
Only one study was related to the community pharmacy setting
(Al-Arifi ,2014). The studies concerning incident reporting were allPlease cite this article in press as: Alsaidan, J., et al. Systematic review of the sa
the Gulf Cooperation Council countries. Saudi Pharmaceutical Journal (2018), hin tertiary care hospitals in large cities of Saudi Arabia, with only
one study educating staff on usage of a medication error reporting
tool in Qatar. It is important to encourage a culture of ‘no blame’
across the GCC, and attempts to report and therefore analyse inci-
dents in smaller healthcare institutions would help identify unique
issues faced by the practitioners in these establishments. There
was a lack of medication safety studies in health care settings of
rural areas. Few studies had a multi-site setting described, which
would make generalisation of results more difficult. In addition,
studies identified errors and provided recommendations but there
were few follow up studies of strategies to address them. Multi-
disciplinary research is a concept that could be integrated within
curricula of medical schools, pharmacy schools and allied health
sciences for enhanced collaboration in focusing on medication
safety. Lack of standardised terminology related to ME studies
has been reported internationally (Lisby et al., 2010) and the stud-
ies included in this review also used a variety of definitions to
determine study outcomes as shown in Appendix C. Even among
younger patients or elderly patients, there is a variety of definitions
used as to what comprises a medication error or what comprises a
drug related problem, even from within the same country. This is
in agreement with (Alsulaimi et al., 2013).
4.3. Recommendations
These findings highlight the need to attempt to standardise GCC
terminology related to ME and ADRs and create a unified platform
to establish patient safety. It must also be kept in mind that in
studies of voluntary reporting, the hospital culture and environ-
ment must be considered. Furthermore these reported numbers
are an underrepresentation of reality as data from rural areas has
not been reported, perhaps incentive scheme for reporting in rural
health areas should be explored. Patient interactions, factors which
would affect their adherence are worth exploring, various studies
reviewed identified that patient non-compliance was a factor in
emergency department use, and in interventional studies, only
10% of interventions were recorded on the patient level. Under-
standing of whether there are specific reasons and identifying of
issues existing with patients in the GCC is a step closer to develop-
ing practical solutions.
In recent years, advances in technology has played a big part in
evolution of medication prescribing and administration; research
evaluating the use of such technology should be encouraged and
supported. The majority of studies were descriptive (n = 43) while
only 11 were experimental in nature i.e. evaluating some kind of
intervention.
5. Strengths and limitations
The strengths of this review are that it is the first systematic
review focussing on ME research within GCC; due to expected pau-
city of studies, conference abstracts were reviewed as well as full
text journal articles, and thus the search was very comprehensive.
While it was difficult to assess the quality of the included abstracts,
we used the same criteria as for the full text articles.
Limitations are that no quality threshold was in place and so full
text articles as well as abstracts were included if they met inclu-
sion criteria without regard to assessment of their quality. This
was done to ensure all potential studies related to ME were
included; while it allows us to present a comprehensive picture
of research within the GCC it does mean that some included
studies were of a higher quality than others. Due to the lack of
standardisation, whether in terminology used or type of data col-
lected, or age groups defined as ‘adult’ or defined as ‘child’ it was
not possible to conduct any form of meta-analysis on the studies
identified. A kappa value was not calculated for the qualityfety of medication use in inpatient, outpatient and primary care settings in
ttps://doi.org/10.1016/j.jsps.2018.05.008
8 J. Alsaidan et al. / Saudi Pharmaceutical Journal xxx (2018) xxx–xxxassessment but the authors ensured that every article included was
assessed by two reviewers and any differences were discussed and
resolved. Also, the degree or the magnitude of harm caused by
improper medication use was not assessed consistently in
studies and could not be reported.6. Conclusions
This systematic literature review highlights several findings.
The first finding is that the literature on ME in the GCC is very
diverse, with a wide range of definitions, denominators and mea-
surement approaches. This also meant it was not possible to calcu-
late an overall incidence of medication error. Future studies could
be improved to provide wider impact and a clearer rationale. Some
suggestions are to enhance coordination between healthcare col-
leges in the region, and to strengthen research methodologies to
increase validity of results and allow them to be placed in context,
for example increase follow up studies. Other suggestions are to
place more emphasis on research of medication errors in the com-
munity pharmacy setting. Increased understanding of patient
behavior and medicine management is also justified. Medication
error research is generally increasing in the region, several uniquePlease cite this article in press as: Alsaidan, J., et al. Systematic review of the sa
the Gulf Cooperation Council countries. Saudi Pharmaceutical Journal (2018),issues are noteworthy to be explored for a better understanding of
errors occurring and solutions to overcome them.
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Safety Research Chair, Vice Deanship of Research Chairs.Appendix A. Search terms used and databases searchedSearch term (terms)fety of medication use in inpatient, outp
https://doi.org/10.1016/j.jsps.2018.05.00Number of hits‘‘G.C.C” OR ‘‘Gulf Cooperation Council” OR Bahrain OR Kuwait OR Oman OR Qatar OR ‘‘Saudi Arabia” OR
‘‘United Arab Emirates”
AND
‘‘Patient Safety” OR ‘‘Medication Safety” OR ‘‘Medication Reconciliation” OR PharmacovigilanceCINAHL = 62
Embase = 740
IPA = 24
PubMed = 654
Science Direct = 356
Web of Science = 79‘‘G.C.C” OR ‘‘Gulf Cooperation Council” OR Bahrain OR Kuwait OR Oman OR Qatar OR ‘‘Saudi Arabia” OR
‘‘United Arab Emirates”
AND
‘‘Adverse drug reaction” OR ‘‘Adverse Drug Event”CINAHL = 14
Embase = 343
IPA = 12
PubMed = 45
Science Direct = 160
Web of Science = 20‘‘G.C.C” OR ‘‘Gulf Cooperation Council” OR Bahrain OR Kuwait OR Oman OR Qatar OR ‘‘Saudi Arabia” OR CINAHL = 1
‘‘United Arab Emirates”
AND
‘‘medication error” OR ‘‘Prescribing error” OR ‘‘prescribing mistake”Embase = 139
IPA = 4
PubMed = 13
Science Direct = 92
Web of Science = 11G.C.C ‘‘OR Gulf Cooperation Council” OR Bahrain OR Kuwait OR Oman OR Qatar OR Saudi Arabia OR
United Arab Emirates
AND
‘‘dispensing error” OR ‘‘dispensing mistake”CINAHL = 0
Embase = 1
IPA = 1
PubMed = 1
Science Direct = 9
Web of Science = 1‘‘G.C.C” OR ‘‘Gulf Cooperation Council” OR Bahrain OR Kuwait OR Oman OR Qatar OR ‘‘Saudi Arabia” OR CINAHL = 0
United Arab Emirates‘‘
AND
”Medication administration error‘‘ OR ”medication administration mistake‘‘Embase = 1
IPA = 0
PubMed = 1
Science Direct = 2
Web of Science = 1‘‘ G.C.C” OR ‘‘Gulf Cooperation Council” OR Bahrain OR Kuwait OR Oman OR Qatar OR Saudi Arabia OR
United Arab Emirates) AND ‘‘medication error” OR ‘‘drug error” OR ‘‘drug mistake”CINAHL = 1
Embase = 139
IPA = 3
PubMed = 15
Science Direct = 76
Web of Science = 10atient and primary care settings in
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e Gulf Cooperation Council countries. Saudi Pharmaceutical Journal (2018), https://doi.org/10.1016/j.jsps.2018.05.00Number of hitsCINAHL = 0‘‘G.C.C” OR ‘‘Gulf Cooperation Council” OR Bahrain OR Kuwait OR Oman OR Qatar OR ‘‘Saudi Arabia” OR
‘‘United Arab Emirates”
AND
‘‘transcription error” OR ‘‘transcription mistake”Embase = 1
IPA = 0
PubMed = 0
Science Direct = 17
Web of Science = 0‘‘G.C.C” OR ‘‘Gulf Cooperation Council” OR Bahrain OR Kuwait OR Oman OR ‘‘Saudi Arabia” OR United
Arab Emirates
AND
‘‘monitoring error” OR
‘‘monitoring mistake”CINAHL = 0
Embase = 0
IPA = 0
PubMed = 0
Science Direct = 2
Web of Science = 0‘‘G.C.C” OR ‘‘Gulf Cooperation Council” OR Bahrain OR Kuwait OR Oman OR Qatar OR Saudi Arabia OR CINAHL = 0
United Arab Emirates
AND
‘‘wrong drug” OR ‘‘wrong drug error” OR ‘‘wrong drug mistake”Embase = 6
IPA = 1
PubMed = 4
Science Direct = 12
Web of Science = 2G.C.C‘‘ OR ”Gulf Cooperation Council‘‘ OR Bahrain OR Kuwait OR Oman OR Qatar OR Saudi Arabia OR
United Arab Emirates
AND
”dosage error‘‘ OR ”wrong dose‘‘ OR ”dosage mistake‘‘CINAHL = 0
Embase = 5
IPA = 2
PubMed = 4
Science Direct = 14
Web of Science = 2G.C.C‘‘ OR ”Gulf Cooperation Council‘‘ OR Bahrain OR Kuwait OR Oman OR Qatar OR Saudi Arabia OR
United Arab Emirates
AND
Cause of medication errorCINAHL = 0
Embase = 1
IPA = 0
PubMed = 4
Science Direct = 5
Web of Science = 0‘‘G.C.C‘‘ OR ”Gulf Cooperation Council‘‘ OR Bahrain OR Kuwait OR Oman OR Qatar OR Saudi Arabia OR
United Arab Emirates
AND
Preventable drug related problemCINAHL = 0
Embase = 0
IPA = 0
PubMed = 2
Science Direct = 1
Web of Science = 0‘‘G.C.C‘‘ OR ”Gulf Cooperation Council‘‘ OR Bahrain OR Kuwait OR Oman OR Qatar OR Saudi Arabia OR
United Arab Emirates
AND
Risk factors for medication errorCINAHL = 0
Embase = 0
IPA = 0
PubMed = 3
Science Direct = 0
Web of Science = 0DataBase Total Number of hits from each databaseCINAHL 78
EMBASE 1376
IPA 47
PubMed 742
Science Direct 746
Web of Science 126Total = 3115atient and primary care settings in
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Appendix C. Definitions used for outcomes by studies included in the review
Term Definition Definition reference 7Used by
Medication error Any preventable event that may cause or lead to
inappropriate medication use or patient harm while
the medication is in control of healthcare
professional, patient, or consumer
NCCMERP (1995, 2005, 2008,
2012)
Al Khaja et al. (2005), Elnour et al. (2007),
Hooper et al. (2009), Khoja et al. (2011), Arabi
et al. (2012), Alshaikh et al. (2013), Alakhali
et al. (2014), Mahmoud et al. (2016), Al-
ghamdy (2015), Aljadhey et al. (2012)a
A failure in the treatment process that leads to, or
has the potential to lead to, harm to the patient
Ferner and Aronson (2006) Al Khaja et al. (2012)
A medication error was defined as an error in the
medication process: ordering, transcription,
dispensing, and administration, and discharge
summaries
Bates et al. (1995)a Almazrou et al. (2015), Aljadhey et al. (2016)
A medication error was defined as an error in the
medication process: ordering, transcription,
dispensing, and administration, and discharge
summaries. Errors included wrong as well as missing
actions
Lisby et al. (2010) Alakhali et al. (2014)
Medication errors were defined as errors in drug
ordering, transcribing, dispensing, administering or
monitoring
Kaushal et al. (2001) Aljeraisy et al. (2011)
Medication errors were defined as any preventable
error in the medication administration process
starting from prescribing and including preparing,
dispensing, administering, monitoring the patient for
effect, and transcribing (eg medication
administration record (MAR)
Miller et al. (2007) Aljeraisy et al. (2011)
A dose of medication that deviates from the
physician’s order as written in the patient’s chart or
from standard hospital policy and procedures
American Society of Health
system pharmacists ASHP
(1982)
Sadat-Ali et al. (2010)
Prescription error Prescription error categories:
– Omissions; major omissions, minor omissions
– Dose or direction error
– Legal requirements not met
– Prescription written for a non-prescription
product
– Unclear quantity prescribed
– Incomplete (‘‘As directed or p.r.n”)
Shaughnessy and Nickel
(1989)
Khoja et al. (2011), Al Khaja et al. (2005), Al
Khaja et al. (2007)
Prescribing error A clinically meaningful prescribing error occurs
when, as a result of a prescribing decision or
prescription writing process, there is an
unintentional significant
(i) reduction in the probability of treatment
being timely and effective
(ii) increase in the risk of harm
Dean et al. (2000) Al Khaja et al. (2012), Al-Dhawailie (2011)
(continued on next page)
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Appendix C (continued)
Term Definition Definition reference 7Used by
Prescribing errors identified were dealt with in one
of two ways: (1) if medication orders were
ambiguous but the pharmacist could determine the
medication intended, he or she would endorse the
drug chart accordingly; (2) if the pharmacist was not
certain of the medication intended or if the error
concerned more fundamental errors in the choice of
drug or dose, the prescriber would be contacted to
resolve the issue
Dean et al. (2002a,b) Al-Dhawailie (2011)
Prescribing errors identified were dealt with in one
of two ways: (1) if medication orders were
ambiguous but the pharmacist could determine the
medication intended, he or she would endorse the
drug chart accordingly; (2) if the pharmacist was not
certain of the medication intended or if the error
concerned more fundamental errors in the choice of
drug or dose, the prescriber would be contacted to
resolve the issue
Dean et al. (2002b) Al-Dhawailie (2011)
Classification of prescribing errors as type A, Type B,
Type C, Type D
Neville et al. (1989) Khoja et al. (2011), Al-Hussein (2008),
Altebenaui et al. (2015)
Prescribing errors may be defined as an incorrect
drug selection for a patient
ASHP (1993) Elnour et al. (2007)
Dispensing error Dispensing errors are mistakes made by staff when
distributing medications to nursing units or directly
to patients in an ambulatory-care pharmacy
Allan and Barker (1990),
Flynn et al. (2002)
Elnour et al. (2007)
Dispensing errors are defined as any inconsistencies
or deviations from the prescription order such as
dispensing the incorrect drug, dose, dosage form,
wrong quantity, inappropriate incorrect or
inadequate labelling, confusing or inappropriate
preparation, packaging, or storage of medication
prior to dispensing
Szeinbach et al. (2007) Al-Arifi (2014)
Administration
error
A drug administration error is error or omission or
commission that occurs in the administration stage
when the medication has to be given by a nurse, the
patient himself or herself, or a caregiver
Flynn et al. (2002) Elnour et al. (2007)
Administration
error
An opportunity for error is defined as any drug
prescribed, any unordered or omitted drug, and any
dose given and any dose omitted
Definitions utilised but not
referenced
Aljamal (2012)
Medication
reconciliation
errors
Discrepancies were classified as omissions (not
ordering a medication used by a patient prior to
admission); commission (adding a medication not
used prior to admission); or wrong dose, frequency,
or route of administration
Definitions utilised but not
referenced
Abu Yassin et al. (2011)
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Drug related
problem
A drug related problem is an undesirable patient
experience that involves drug therapy and that
actually or potentially interferes with a desired
patient outcome
Strand et al. (1990) Al-Olah and Al Thiab (2008), Al-Arifi (2014),
Alghamdy et al. (2015)
An event or circumstance involving drug therapy
that actually or potentially interferes with the
desired health outcome
Pharmaceutical care network
Europe (PCNE) (1999, 2008,
2010, 2012)
Hooper et al. (2009), Rashed et al. (2012),
Rashed et al. (2013), Kheir et al. (2014),
Alghamdy et al. (2015), Al Hamid et al.
(2016)
Adverse drug
event (ADE)
ADEs are any noxious, unintended, and undesired
reaction that occurs because of a drug in doses
normally used in man for prophylaxis, diagnosis, or
therapy of disease or for the modification of
physiologic function, or that is caused by drug
interactions, allergic drug reactions and medication
errors
WHO (1999) Al-Tajir and Kelly (2005)
An adverse drug event is an injury caused by a
medication, which include both adverse drug
reactions (an effect which is noxious and
unintended, and which occurs at doses used in man
for prophylaxis, diagnosis or therapy) as well as
harmful effects arising from errors at any stage
including ordering, transcribing, dispensing,
administering, or monitoring of a drug
Bates et al. (1995b), Jha et al.
(1998), Gandhi et al. (2000)
Aljadhey et al. (2013)a, Aljadhey et al. (2016)
An ADE was defined as an injury due to a medication,
including both adverse drug reactions and injuries
caused by medication errors
Nebeker et al. (2004) Al-Ghamdi et al. (2012)
Potential adverse
drug event
A potential adverse drug event is a medication error
with the potential to cause an injury but which does
not actually cause any injury, either because of
specific circumstances, chance, or because the error
is intercepted and corrected
Morimoto et al. (2004) Aljadhey et al. (2013)a, Aljadhey et al. (2016)
Non preventable
adverse drug
reaction
Non preventable adverse drug reactions, also known
as adverse drug reactions, are defined by the WHO as
‘a response to a drug which is noxious and
unintended, and which occurs at doses used in man
for prophylaxis, diagnosis, or therapy of disease, or
for the modifications of physiological function
WHO (2014) Aljadhey et al. (2016)
Potentially
Inappropriate
medications
Potentially inappropriate medications are
medications in which the risks of use outweigh the
benefits
Rancourt et al. (2004) Al-Omar et al. (2013)
Beer’s criteria-Potentially inappropriate medication
list as updated by Fick and colleagues in 2003
Fick et al. (2003) Al-Omar et al. (2013)
American Geriatrics Society
Beers Criteria Update Expert
Panel (2012)
Al Odhayani et al. (2016)
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Appendix D. Data extracted from included studies
Reference Country Design Definitions used for study
outcomes
Method of error
identification
Medication safety aspect
analysed
Reported results
I- Studies describing medication errors
a. Studies describing prescribing errors (n = 17)
Al Khaja et al.
(2005)
Bahrain Retrospective
clinical
prescription review
A medication error is defined
as (NCCMERP, 2012)
Audit of prescriptions to
screen for errors (for a two
week period)
Identification of prescribing
errors and their
determinants in a primary
care setting
77,511 prescriptions audited,
5959 (approximately 8%) were
identified to contain errors. The
5959 prescriptions contained
16,901 medications, of which
13,630 (approximately 85%) were
with errors. Major errors of
omission associated with topical
preparations were significantly
higher than those with systemic
preparations. However,
prescriptions with systemic
preparations had a higher rate of
commission errors
Irshaid et al.
(2005)
Saudi
Arabia
Retrospective
analysis of
prescriptions
None used Prescriptions were analysed
for the essential elements to
be included in the
prescription order and the
data recorded using a coding
key. The information within
the prescription was judged
‘‘unclear” if one word was
not written clearly and
‘‘unreadable” if none of the
three investigators present
during the screening session
could read it
Prescriptions written by
physicians were screened for
the stated essential elements
Three thousand seven hundred
ninety-six prescriptions analysed,
approx. seven percent of the total
prescriptions written during that
period. The name and signature of
the prescriber was included in
approx. 83% and 82% of
prescriptions respectively. The
handwriting of the prescriber was
not clear in approx. 64% of the
prescriptions. The strength of the
medications was included in
approximately 26% of the
prescriptions
Al Khaja et al.
(2006)
Bahrain Cross- sectional
prescription review
Major errors of omission,
major errors of commission
were defined as per Al Khaja
et al. (2005). The British
national formulary (#37;
2002) was referred to for the
dose ranges and paediatric
doses were calculated as per
Insley, 1996
Prescriptions issued to
infants were analysed for
prescribing pattern and
prescribing errors
Nationwide study evaluated
the prescribing profile and
prescribing errors of
antimicrobials in infants, in
primary care
Of 2282 dispensed prescriptions,
543 included an antimicrobial
agent. Of these:
119 were prescribed at
subtherapeutic doses
28 at supratherapeutic doses. The
remainder 394 at therapeutic
doses
Major errors of omission from
prescription involved duration of
therapy, dosage form. Errors of
commission commonly included
dosing frequency and dosage of
antimicrobials
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Al Khaja et al.
(2007)
Bahrain Retrospective
clinical
prescription review
Definitions were as per Al
Khaja et al. (2005)
Prescriptions issued for
infants were collected and
reviewed over a 2-week
period from 20 health
centres
The trends in drug utilisation
including off-label drug
prescribing and the
prevalence, and the type of
medication-related
prescribing errors
In 2282 dispensed prescriptions a
total of 5745 medications were
included. 2066 (approximately
91% of the prescriptions) were
identified to contain major errors
of omission, commission, and
errors of integration. Errors of
omission accounted for
approximately 54%, and included
length of therapy/quantity and
dosage form. Errors of
commission accounted for
approximately 44%, commonly
incorrect dosing frequency and
incorrect dose/strength.
Prescribing of an off-label drug
was observed in approximately
16% of cases
Alkhaja et al.
(2008)
Bahrain Prospective
collection of
prescriptions for
two consecutive
cohorts
Prescribing errors were
defined according to the
definitions of:
– Shaughnessy and Nickel
(1989)
– Al Khaja et al. (2005)
All prescriptions issued by
12 final year residents in
May 2004 and 14 final year
residents in 2005 were
collected. Prescriptions were
screened by one author of
this study, and subsequently
audited by another author
The percentage of omission
commission and integration
related errors in
prescriptions written by final
year residents were
calculated
A total of 2692 prescriptions were
collected. Eighty-eight percent
were identified to include major
errors of omission. Dosage form
and length of treatment were
frequent omissions. As for errors
of commission, dosing frequency
was the most common incorrectly
stated component
Al-Hussein
(2008)
Saudi
Arabia
Cross-sectional
audit of
prescriptions
Nonconformities were
classified according to the
component of prescribing
process involved. . .
patient, provider,
prescribing, drug/dispensing
or others (as described by
study author). A second
classification was used
according to that of Neville
et al. (1989)
Prescriptions were collected
during audits done
fortnightly by sampling
random selection of 30
prescriptions, for a total of
330. Information about each
prescription was entered in a
database by the pharmacists
and based on yes-no answers
to status of compliance to
the indicators, an automated
decision was made on
conformity
To explore the degree of
prescription conformity to
the prescribing guidelines at
primary care. This is in order
to develop and incorporate a
systematic process in
prescription errors in
primary care and provide the
health care providers with
feedback
Approximately 13% of
prescriptions fully conformed to
the given guidelines, while the
remainder (87%) did not conform.
Less than 1% of the
inconsistencies were potentially
harmful to the patient, approx.
77% had possible negative effect
on the pharmacist’s work. Patient
information was deficient in
approx. 17% of cases
Khoja et al.
(2011)
Saudi
Arabia
Cross-sectional
audit of
prescriptions
prescribed or
dispensed over one
full working day
Defined prescription errors
as per US Pharmacopeia,
1995
Utilised the classification of
Neville et al. for system for
classifying prescription
errors to classify errors as
Samples of prescriptions
were analysed to obtain
evidence about the nature
and extent of errors.
Prescriptions containing
errors were allocated an
error classification following
Prescriptions errors and
comparison between private
and public sectors
Public clinics – 1182
prescriptions (2463 prescribed
drugs). Private clinics – 1200
prescriptions (2836 prescribed
drugs) = Total (5299) drugs.
Prescribing errors were found on
990 (approximately 19%). Both
(continued on next page)
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Appendix D (continued)
Reference Country Design Definitions used for study
outcomes
Method of error
identification
Medication safety aspect
analysed
Reported results
type A, B, C or D Neville et al.
(1989)
a discussion between one
investigator and pharmacists
involved
type B and type C errors were
more common in public than
private PHC centres. Type D were
more frequently found on private
than public clinic prescriptions
Al-Dhawailie
(2011)
Saudi
Arabia
Not stated The sited medication errors
were categorized according
to the definition of Dean
et al. (2002a) and (2002b)
The inpatient medication
charts and hand written
orders were identified and
rectified by ward and
practicing pharmacists
within inpatient pharmacy
services. Data were collected
and evaluated. The causes of
problem were identified and
dealt with in one of two
ways
To detect the incidence of
prescribing errors for
hospitalized patient, to
evaluate the clinical impact
of pharmacist intervention
on the detection of these
errors
Of 1580 prescriptions, 113
(approx. 7%) were detected to
contain prescribing errors and
intervened by the clinical
pharmacists. The errors of wrong
strength and wrong
administration frequency of the
prescribed drug were the most
errors reported (approx. 35%, and
23%, respectively). Other errors as
wrong patient/ drug or wrong
dose were also encountered. The
prescribing errors encountered
were of varying severity. Multiple
factors were identified: lack of
training for medical students
about this during undergraduate
studies, work load, stress and
ineffective communication
between healthcare professionals
Al-Jeraisy et al.
(2011)
Saudi
Arabia
Retrospective
cohort study
A prescription error was
defined per (Kaushal et al.
(2001) as well as (Miller
et al. (2007) and Lesar et al.
(2006), Abushaiqa et al.
(2007) and Kohn et al. (2000)
Physical inspection of
physician medication and
reviews of patients files
Determine incidence and
types of medication
prescription errors, and
identify some potential risk
factors in a paediatric
inpatient tertiary care
setting
Out of 2380 orders examined in
the five week period, error rate
was 56 per 100 medication orders
(CI: 54.2%, 57.8%) Dose errors
accounted for approx. 40% of
these errors, while incorrect dose
errors approx. 21%. The errors
occurred more frequently with
intravenous route of
administration and one third
occurred in paediatric intensive
care unit
Al Khaja et al.
(2012)
Bahrain A retrospective,
nationwide audit of
prescriptions
Medication error has been
defined according to the
definitions of (Ferner and
Aronson (2006)
A prescribing error has been
defined according to the
definitions of (Dean et al.,
2000)
The eligible prescriptions
were carefully audited by
the first author and then
independently reviewed by
second and third authors.
Discrepancies were resolved
by discussion
This study was carried out to
identify the frequency and
nature of medication
prescribing errors the
medication prescribing
errors pertaining to
cardiovascular/antidiabetic
medications in prescriptions
Two thousand, seven hundred
and seventy-three prescriptions
were analysed. Approximately
26% of prescriptions had
medication prescribing errors. No
significant differences with
respect to overall errors were
evident in prescriptions ordered
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written by primary care
physicians
by the family physicians and
general practitioners. Prescribing
errors commonly involved lipid
lowering medications, b-blockers,
high dose metformin and high
dose glibenclamide
Al Shahaibi
et al. (2012)
Oman Observational,
retrospective
None stated Retrospective analysis of 900
prescriptions from four
different hospitals. Each
prescription was checked
five times, once for the
superscription errors, then
second inscription, next for
the subscription errors,
followed by legal errors, and
last for reviewing it all
To evaluate and analyse the
handwritten outpatient
prescriptions and associated
error of omissions
Nine hundred handwritten
outpatient prescriptions were
analysed; a total of 1471 drugs
were prescribed.
Most common type of
superscription error of omission
was found to be age and gender.
The most common inscription
omissions were of dosage form
and strength/dose of drug.
Subscriptions omission were
omission of prescriber’s
signature, while date of
dispensing medication was
omitted in 100% of prescriptions
Aseeri (2013) Saudi
Arabia
Retrospective
cohort study.
A dosing error was defined
as per McPhillips et al.
(2005). A dosing error was
defined as the presence of an
antibiotic dose that was
110% or more of the maxi-
mum recommended daily
dose or below 90% of the
minimum recommended
daily dose
A retrospective cohort study
of 300 randomly collected,
physician-prescribed
antibiotic order sheets was
performed over a 2-week
period within different
settings in the tertiary
hospital (inpatient unit,
ambulatory care clinic,
emergency department)
300 prescriptions collected
in pre implementation phase
and post implementation
phase 300 sheets were
collected
To compare the rate of
dosing errors for antibiotic
orders in paediatric patients
before and after the
implementation of a
standard dosing table. It is
for oral or parenteral
antibiotics with pre-
calculated dosage for
different weight ranges
Physician compliance with the
antibiotic dosing standardization
policy after implementation was
62%. The dosing standardization
policy reduced the rate of dosing
errors from approx. 34% to
approx. 5% (P = 0.0001), and
weight documentation on the
antibiotic prescriptions improved
from approx. 65% to approx. 85%
(P = 0.0001)
Albarrak et al.
(2014)
Saudi
Arabia
Prospective study None stated Handwritten prescriptions
were received from three
outpatient departments
whereas electronic
prescriptions were collected
from the paediatric ward.
The handwritten
prescriptions were evaluated
for completeness and
legibility by two
pharmacists. The
comparison between
To assess the legibility and
completeness of
handwritten prescriptions
and compare with electronic
prescription system for
medication errors
Three hundred ninety-eight
prescriptions (199 handwritten,
199 electronic prescriptions)
were assessed. Seventy-one
(approx. 36%) of handwritten and
5 (approx. 3%) of electronic
prescriptions were identified to
contain errors. A significant
statistical difference (P < 0.001)
was observed concerning omitted
dose and omitted route of
administration. The rate of
(continued on next page)
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Appendix D (continued)
Reference Country Design Definitions used for study
outcomes
Method of error
identification
Medication safety aspect
analysed
Reported results
handwritten and electronic
prescription errors was
assessed based on the
validated checklist adopted
from previous studies.
Delgado et al. (2007), Bobb
et al. (2004), Al-Jeraisy et al.
(2011). The prescriptions
were evaluated for legibility
by two pharmacists accord-
ing to a three point legibility
scoring Likert scale similar to
the study Mendonca et al.
(2010)
medication prescription
completeness in handwritten
prescriptions approximately
ranged from 88% to 91% from the
three different clinical units. In
handwritten prescriptions there
were drug interactions evident
but in the electronic prescriptions
drug interactions were not
reported
Altebenaui
et al. (2015)
Saudi
Arabia
Not stated As per Neville’s classification
(1989). Prescription errors
were classified as major
(potentially life threatening),
minor (non-life threatening)
or trivial
Retrospective cross sectional
analysis of physician
prescriptions that were
issued over a one month
period. One thousand
prescriptions were randomly
selected for review
Identifying the types and
frequency of prescription
errors from different
departments, outpatient and
emergency room (ER).
Patient file numbers and
medication dosages were missing
in more than 20 and 40%, of
reviewed prescriptions,
respectively.
At least 30% of the reviewed
prescriptions were deemed to
have had illegible handwriting.
Non-life threatening items
including age, physician signature
and stamp, date, sex diagnosis
were missing in more than 50%.
Weight was missing from all
transcripts. Prescriptions written
by ER physicians had more
missing items compared to those
wrote by outpatients clinics (P =
0.01)
Youssef et al.
(2015)
Saudi
Arabia
Retrospective
study
To calculate renal function
the modification of diet in
renal disease (MDRD)
formula was used, and
Cockgroft Gault, as per
National Institute of
Diabetes and Digestive
Kidney Diseases (2014)
Detailed prescriptions were
abstracted from the
electronic medical record.
Examination of the data was
performed for medications
that are renally cleared and/
or potentially nephrotoxic.
These medications were
then categorized according
to the CDSS internal
database into two types, as a
contraindicated medication
OR not a contraindicated
medication
Determination of various
types of contraindicated
medications that are
administered to patients
with renal insufficiency by
physicians who override
alerts provided by the
Computerized Decision
Support Systems (CDSS)
Out of the 314 prescriptions that
were renally cleared and/or
potentially nephrotoxic, 44 (14%)
were for contraindicated
medications. The contraindicated
medications ordered were limited
to: aspirin, gliclazide,
nitrofurantoin; and
spironolactone
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Alanazi et al.
(2015)
Saudi
Arabia
Cross-sectional Not stated Reviewing charts and
prescriptions of patients
complaining of infections.
The prevalence of an
inappropriate antibiotic
prescription was accounted
as a physician order with at
least one type or more of
errors divided by total
number of prescriptions and
multiplied by 100
Study purpose was to assess
the prevalence and
predictors of antibiotic-
related prescription errors
among patients admitted to
an emergency centre at a
tertiary health care facility
Adults (>15 years) were approx.
61%, whereas paediatrics (<15
years) were approx. 39%. Majority
of patients were not screened for
antibiotic allergies (approx. 92%).
Three main antibiotic categories
were prescribed in both age
groups: penicillin, cephalosporin,
and macrolide.
The prevalence of inappropriate
antibiotic prescriptions with at
least one or more types of errors
was approx. 46%, which was
significantly higher among
paediatrics compared to adults (P
= 0.001). Physicians tend to
prescribe antibiotics with higher
than the recommended dosages
and/or frequencies
Mahmoud
et al. (2016)
Saudi
Arabia
Retrospective chart
review chart study
(National Coordination
Council for Medication
Errors Reporting and
Prevention NCC MERP) index
(2005)
Four month retrospective
chart review chart study. The
severity of prescribing errors
was determined by two
independent reviewers
Aim was to determine the
incidence of prescribing
errors using a validated
definition. The main study
outcomes were the
percentage of medication
orders and hospital
admissions with prescribing
errors; and the types of
prescribing errors
Six hundred ninety-one
prescribing errors were in 2033
patient files. The incidence of
prescribing errors was 3.6 (95% CI,
3.3–3.9) per 100 prescriptions.
Per 100 admissions the
prescribing error incidence was
33.9 (95% CI, 31.5–36.6) and 76.5
(95% CI, 70.9–82.3) per 1000
patients days. The most common
prescribing error type was dosing
errors, while antibiotics were the
most common drug class involved
with prescribing errors
I- Studies describing medication errors
b. Studies describing administration errors (n = 2)
Aljamal (2012) Saudi
Arabia
A cross-sectional
prospective
observational
study
An opportunity for error is
defined as any drug
prescribed, any unordered or
omitted drug, and any dose
given and any dose omitted.
Disguised method was used.
Definitions utilised but not
referenced
Medication administration
error was calculated by
dividing actual errors by the
total number of
opportunities for errors.
Disguised method was used.
The nurses were
accompanied during
medication administration.
These medications were
then registered and
compared with eligible
prescriptions in the
medication chart
The objective of this study
was to assess the frequency,
type, and potential clinical
consequences of medication
administration errors in a
tertiary hospital
A total of 169 medication
administration errors were
observed out of 2112
opportunities for error,
representing an error rate of eight
percent. Five types of errors were
detected including dose omission
(35%), wrong dose (5%), wrong
drug (2%), wrong technique (1%)
and wrong time (57%). Majority of
errors did not cause harm and six
errors were prevented before
reaching patients
(continued on next page)
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Appendix D (continued)
Reference Country Design Definitions used for study
outcomes
Method of error
identification
Medication safety aspect
analysed
Reported results
Almazrou et al.
(2015)
Saudi
Arabia
A cross-sectional
observational
study
A medication error was
defined as per Bates et al.
(1995)
Interviews of the mothers
were performed by
pharmacy students
The mothers were required
to demonstrate how to
measure 5 mL of
paracetamol syrup using a
cup and a syringe and 1 mL
of paracetamol syrup using a
dropper while being
observed, dosing errors were
evaluated visually
A cross-sectional study in
which mothers were
observed as they used a set
of commonly available
dosing devices which are a
dosing cup, syringe, and
dropper
Of 575 participants these
measured an accurate dose of
paracetamol using:
an oral dosing syringe 334 (58%)
dropper-286 (50%) dosing cup. As
for errors, participants measured
more than the intended dose with
the dosing cup and less than the
intended dose with the dropper
I- Studies describing medication errors
c. Studies assessing errors in medication history and medication reconciliation errors (n = 5)
Rehmani
(2001)
Saudi
Arabia
Prospective cross-
sectional survey
None Specified Nurses recorded a
medication list during triage
in the electronic medical
record (EMR). This home
medication list was not
placed in the emergency
department chart. Records
were then reviewed by a
physician. The research
generated home medication
list was compared to the
standard medication list and
the number of omissions,
duplications, and dosing
errors was determined
Evaluate the accuracy of
medication history taking in
emergency department
triage
Two thousand one hundred
seventy adults completed the
survey (88% of patients
approached).
Discrepancies in medication lists
obtained during triage were
documented in (52%) of patients.
The dosing or frequency error was
(62.0%). Discontinued
medications were included,
additional medications were
omitted, and patients reported
taking a non-prescription
medication not listed in the
electronic medical record
Abu Yassin
et al. (2011)
Saudi
Arabia
A prospective
observational
study
Definition for discrepancies
utilised but not referenced.
Discrepancies were classified
as omissions (not ordering a
medication used by a patient
prior to admission);
commission (adding a
medication not used prior to
admission); or wrong dose,
frequency, or route of
administration
A pharmacist screened the
patient’s chart and reviewed
recent lab results and
interviewed patients to
acquire comprehensive
medication history. All
information obtained from
patients was compared with
medications recorded by the
physician upon the patients’
admissions to the hospital
To investigate the role of
pharmacists in identifying
discrepancies in medication
history at admission to
hospitals
Sixty patients were interviewed,
taking a total of 564 medications.
At least one discrepancy was
found in 37% of patients, and the
most common discrepancies
observed were omissions of
medications and dosage errors
Al Anany et al.
(2012)
Qatar Not stated but from
the description it is
a cross sectional
interventional
study
None stated Clinical pharmacists
conducted interviews with
the patient or caregiver in
the first 24 h of admission or
transfer to review their
To highlight the impact of
medication reconciliation
conducted by clinical
pharmacists on reducing
adverse drug events during
For the 52 patients interviewed,
the total number of medications
reconciled was 263. Of these, 93
medications (35%) required the
intervention of clinical
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medications. The collected
data were then compared
with the current medication
list prescribed after
admission or transfer. The
interventions were done
through a medication
reconciliation process on
specially prepared form
admission and transfer by
identifying different types of
interventions
pharmacists. Omission was the
most common type of error,
followed by wrong doses and
medications with no indication
Aljadhey et al.
(2013)b
Saudi
Arabia
Observational
Cross-sectional
None stated Discrepancies (number and
type) were recorded in a
data collection sheet. Then
the discharge counselling
pharmacist conducted
medication reconciliation by
comparing the discharge
medication list with the best
possible medication history
provided by hospital
pharmacy records
To identify the discrepancies
number and type upon
conducting discharge
reconciliation
One-hundred and seventy-three
patients were screened and 568
discrepancies were identified in
121 patients, with a mean of 4.7
± 2.8 per patient. Eighteen
percent of patients presented
with at least one unintentional
discrepancy, which were
omission, commission, changed
frequency, duplication and wrong
duration
Sonallah et al.
(2014)
Qatar Retrospective,
descriptive and
post-interventional
study
None stated A standardized medication
reconciliation form was
developed and used by
clinical pharmacists as a tool
to detect the number and
types of medication
discrepancies and document
clinical pharmacist
interventions
This study was conducted to
evaluate the medication
reconciliation (MR) process
as a newly initiated service
by clinical pharmacists.
Two hundred thirty-two forms
were collected and 1640
medications were reconciled. One
hundred and seventy-eight cases
(approximately 77%) had
medication discrepancies upon
hospital admission, Most of the
discrepancies were due to
medication omissions, incorrect
dosages, and different
medications. Clinical pharmacists’
interventions were carried out in
150 cases (approx. 65%)
I- Studies describing medication errors
d. Studies assessing potentially inappropriate medication use (n = 2)
Al-Omar
(2013)
Saudi
Arabia
A retrospective
review of
prescription
records
Potentially inappropriate
medication (PIM) defined as
the definition of: Rancourt
et al. (2004)
Beers criteria (as updated by
Fick et al. (2003) were used
to identify the PIMs
The source of the data was
outpatient pharmacy
prescription records at
Riyadh Military Hospital
(RMH) for 2002, 2003 and
2004. Data were re-coded,
new variables were created
and the total cost of
medications was calculated
To explore the prevalence of
(PIM) use in the elderly, to
identify the trends and
patterns of prescribing such
medication, and to calculate
the associated direct
medication cost of such
practice in Saudi hospital
A total of 20 521 PIM were
identified. The prevalence of PIM
for 2002, 2003 and 2004 was
approx. 3%, 2% and 2%,
respectively. A total of approx.
43% of the patients had filled a
prescription of one PIM, the
remainder had filled a
prescription with 2 or more PIM.
Digoxin accounted for approx.
24% of these PIM. Other
medications involved were
(continued on next page)
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Appendix D (continued)
Reference Country Design Definitions used for study
outcomes
Method of error
identification
Medication safety aspect
analysed
Reported results
cardiovascular drugs, iron
supplements, and laxatives. The
total direct cost that was
associated with inappropriate
prescribing was 518 314 Saudi
Riyals (United States $138 217,
where one US dollar = 3.75 Saudi
Riyal)
AlOdhayani
et al. (2016)
Saudi
Arabia
Retrospective The study participants were
elderly, as defined by the
World Health Organisation
(WHO, 2011)
Beers crtieria (Fick et al.,
2003) was used to determine
the number of PIMs
Data were collected from
patients’ medical electronic
and non-electronic records,
and from the main hospital
laboratory framework. The
number of PIMs was
determined by using Beers
criteria 2012 and a review of
the literature
This study aimed to establish
the extent of inappropriate
drug prescription for and use
by elderly patients
Of the 798 included patients; 419
were using one or more PIMs. The
most common PIM was a high
dose of ferrous sulphate, in about
33% of the participants compared
to the rest of the group (P <
0.001). Analgesics, opioids,
antispasmodics and muscle
relaxants, were frequently
prescribed
I- Studies describing medication errors
e. Studies assessing more than one type of medication error (n = 8)
Dibbi et al.
(2006)
Saudi
Arabia
A retrospective
review of patient
medical records
None stated Retrospective review of
medical records for adult
hospitalised patients 18
month period
The study focused on types,
causes, contributing factors,
frequency of medication
errors and patients outcome
Two thousand six hundred
twenty-seven medical records
were reviewed and 3963 errors
were identified. One thousand
five hundred fifty-nine files
contain one error, 800 files with 2
errors and 268 with 3 or more
errors. The most common was
wrong strength (confusion
between microgram and
milligram). Other errors included
wrong route of administration,
wrong dosage form and wrong
dose which included over, under
and extra doses. Medication
errors were possible to be one of
the related factors among 26
deaths
Causes of error cited- Human
factors as miscommunication
(including misinterpretation of
order and written
miscommunication)
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Elnour et al.
(2007)
United
Arab
Emirates
Prospective
interventional
study
A medication error is defined
by the National Coordinating
Council for Medication Error
Reporting and Prevention
(NCC MERP 2005)
Prescribing errors defined as
per American Society for
Hospital Pharmacists ASHP
(1993)
Dispensing errors defined as
per Allan and Barker (1990)
and as per Flynn et al. (2002)
Drug administration error
defined as per Flynn et al.
(2002)
A systematic random sample
of the inpatient nursing staff
completed a structured
program consisting of
pre/post self-reported
questionnaire on a new
medication safety program
(Med Safe Tool) for
medication error reporting
The generated medication
errors reported were edited
by the clinical pharmacists,
and root cause analysis was
performed. The research
clinical pharmacists
reviewed and assessed the
accuracy of each true
medication error incident
report
Demonstrates the benefits of
implementing a
computerized medication
safety program (Med Safe
Tool) with regard to
reporting all types of
medication errors
The number of medication errors
reported to the Med Safe Tool
before the program (n = 41)
versus (n = 57) after the
structured program. There were 9
types of medication errors (Most
errors occurred during the
medication administration stage].
Most of the medication errors
pertain to the outcome category
and severity code B, as per NCC
MERP 2005
Sadat-Ali et al.
(2010)
Saudi
Arabia
Retrospective The definition of medication
error was of Health System
Pharmacists (ASHP, 1982)
The incident reports during
two year period were
collected and analysed for
pertinent data. The medical
charts were evaluated
The prevalence and
characteristics of medication
errors reported
Twenty-three thousand and nine
hundred fifty-seven patients
admitted and 38 medication
errors reported. Most common
errors: missed medication,
expired medication, wrong time
of medications
There were three adverse events
where the patients had extended
hospital stay. No patients died or
experienced permanent harm
Hemida, et al.
(2011)
Saudi
Arabia
Observational
study
None specified All incident reports that
were voluntarily reported
from the neonatal intensive
care unit were reviewed for
medication errors From
these reports, the incidence
and nature of medication
errors was estimated
To study the nature of
medication errors of
neonates admitted to level III
neonatal intensive care unit
(NICU)
There were 66 incident reports
involving medication errors with
estimated incidence of one per
250 admissions. Most prevalent
type was dispensing error (91%).
Nurses were involved more
commonly than pharmacists and
physicians. The most common
type of MEs for nurses: delay/not
giving; pharmacists: delay /not
dispensing and physicians;
incomplete prescriptions. The
most common medications
involved were antibiotics and
total parenteral nutrition
(continued on next page)
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Appendix D (continued)
Reference Country Design Definitions used for study
outcomes
Method of error
identification
Medication safety aspect
analysed
Reported results
Arabi et al.
(2012)
Saudi
Arabia
Descriptive study
of paper based
incident reports
Medication error as per
National Coordination
Council for Medication
Errors Reporting and
Prevention NCC MERP) index
(2008)
Evaluated submitted
incident reports from all
hospital areas including the
intensive care unit for one
year period
To examine the rates and
categories of incident
reports, both hospital-wide
and in the intensive care unit
(ICU)
There were 38,171 hospital
admissions. Total of 3041
incident reports from all hospital
areas, yielding a rate of 5.8 per
1000 patient days. Medication
errors accounted for
approximately 7% and 13% of all
incident reports from the hospital
and the ICU respectively
Alshaikh et al.
(2013)
Saudi
Arabia
Cross sectional
review of
occurrence/variant
reports related to
medication errors
(National Coordination
Council for Medication
Errors Reporting and
Prevention NCC MERP) index
(2008)
All occurrence/variant
reports related to medication
errors were documented on
a hospital web-based
medication error form that
was designed to capture
information on all aspects.
Medication error reports
were reviewed and reported
at quarterly intervals over a
1-year period
The objective of the current
study was to explore the rate
of reporting medication
errors and factors associated
with the root causes of these
errors in a large tertiary
teaching hospital
The medication error rate over
the 1-year study period was 0.4%
(949 medication errors for
240,000 prescriptions). During
this period, approx. 1.5% of the
errors were categorized as
resulting in any harm to the
patient (all category E).
Medication errors were reported
predominantly at the prescribing
stage (approx. 89%). Illegible or
unclear handwriting (17%) was a
reported cause of error
Al-Khani et al.
(2014)
Saudi
Arabia
Retrospective
study including
incorrect drug
error reports
Medication prescribing error
was defined as per Dean
et al. (2000)
The study was a review of
incorrect drug error reports
for 21 month period. Reports
were reviewed by two
pharmacists to ensure
accuracy of data
classification
The objective was to explore
factors that help pharmacists
identify and thus prevent
harm from incorrect drug
prescribing errors in an
ambulatory care setting.
During the specified period 2073
prescribing errors were reported
in the hospital safety reporting
system. Incorrect drug
prescribing errors occurred at a
rate of 10% (203 reports). Factors
that allowed the pharmacist to
identify incorrect drug
prescribing errors before
dispensing the medication
include- reviewing the
mandatory electronic
prescription indication field,
reviewing the patient medication
history
Alakhali et al.
(2014)
Saudi
Arabia
Retrospective
prescription review
A medication error was
defined as per National
Coordinating Council for
Medication Error and
Prevention (NCCMERP) 2005,
and as per Lisby et al. (2010)
Retrospective study
reviewing all the
prescriptions for two months
To detect the medication
errors in the different stages
of medication use process
such as prescribing,
transcription, dispensing and
administration
Total 1850 opportunities for
errors registered.
Prescribing errors were 10% of
these errors, dispensing errors
and administration errors both
approx. 0.5%
No transcription errors were
observed
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II- Studies describing drug related problems (n = 5)
Al-Olah and Al
Thiab
(2008)
Saudi
Arabia
Prospective
observational
study
A drug-related problem
(DRP) was defined as per
Hepler and Strand (1990).
On a daily basis, the
investigators collected data
on a data collection sheet for
all emergency department
(ED) admissions during the
previous 24 h
To identify and evaluate
admissions due to DRPs
through the ED
Of 557 patients admitted through
the ED, 82 were admissions due
to DRP (approx. 15%). Fifty-three
were definite, 29 were probable.
The most common definite DRP
admission was due to failure to
receive medications followed by
adverse drug reactions and drug
overdose
Rashed et al.
(2012)
Saudi
Arabia
A prospective
cohort study
DRP were defined as per the
(PCNE) Pharmaceutical Care
Network Europe, 2008)
DRPs were identified by a
researcher reviewing the
medical records of children
attending the ED during a
three month period
DRPs incidence in children
attending an ED was
calculated, preventability
was determined and severity
assessed
The results from KSA arm of the
study: Total Patients (n = 143)
Fifty-two DRPs identified; most
common types were dosing
problems followed by drug choice
problems. Fifty-one of the 52
DRPs identified were preventable;
and approx. 77% of minor severity
Al-Arifi et al.
(2014)
Saudi
Arabia
Prospective cohort
observational
study
Drug related problems (DRP)
were defined according to
the (Strand et al., 1990
Information was taken by
one of the authors from the
patient file and/or patient
interviewing using the
specially designed data
collection sheet
Aims were:
– To prospectively deter-
mine the incidence and
types of emergency
department (ED) visits
and admissions due to
drug related problems
(DRPs) at a tertiary
hospital
– To assess the severity and
preventability of the drug
related admissions or
visits
– To identify the drugs and
patient groups that are
most commonly involved
Random selection of 300 patients
presenting to emergency
department of which, 56 (approx.
19%) were presented to ED due to
DRPs. The most common DRPs
was due to adverse drug reactions
(approx. 30%) and patients’ non-
compliance (approx. 30%),
followed by untreated indication
then drug interactions;
supratherapeutic and
subtherapeutic dose. It was noted
that adverse drug reaction
incidence was almost double in
female patients than male (11:6)
Alghamdy
et al. (2015)
Saudi
Arabia
Retrospective
review of medical
records of selected
emergency
department
admissions
Definitions of DRP:
(Strand et al., 1990)
While medication error is
defined as (Lisby et al., 2010)
and (NCCMERP 2012)
Files of suspected cases of
DRPs reporting to ED in the
12 month period were
scrutinized. Suspicion arose
from the hospital record
system based on Diagnosis
Code Numbers (ICD-9-CM,
Professional 2010) and from
triggers, such as some drugs,
laboratory tests, and signs
and symptoms pointing to
DRPs
To estimate prevalence of
admissions as a result of
DRPs at the emergency
department (ED)
Of 5574 admissions, 253 were
DRPs. They were categorised as:
non-compliance to treatment
(approx. 44%), overdose toxicity
and side effects of drugs (approx.
20%), drug-interactions (approx.
12%), accidental and suicidal drug
ingestions (approx. 10%), drug
allergy (4%), Over 60% of DRPs
were preventable and approx. 4%
of patients died
(continued on next page)
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Appendix D (continued)
Reference Country Design Definitions used for study
outcomes
Method of error
identification
Medication safety aspect
analysed
Reported results
Al Hamid et al.
(2016)
Saudi
Arabia
Retrospective
medical record
review
Medicine-related problem
(MRP) is defined as per
Pharmaceutical Care
Network Europe (PCNE
2010)
A data collection tool was
developed based on the
Pharmaceutical Care
Network Europe (PCNE)
classification tool (PCNE
2010). The tool was used to
extract data from each
medical record
The aims of this study were
to:
– Investigate hospitalisa-
tions due to medicine
related problems (MRP).
In adult patients with car-
diovascular disease and/
or diabetes mellitus
– Determine the major
causes and risk factors
contributing to medicine
related problems
– Identify the main medici-
nes associated with medi-
cine related problems
Out of 150 medical records
reviewed, 94 medicine related
problems were identified of
which approx. 67% resulted in
hospitalisations. Commonly
encountered medicine related
problems were treatment
effectiveness and adverse drug
reactions, accounting for approx.
98%. Polypharmacy was a major
risk factor associated with
medicine related problems.
Insulin was implicated in approx.
47% of MRPs while oral
antidiabetic agents.
Approximately 34% of the MRPs
were related to cardiovascular
medicines, including
antihypertensive (i.e., ACEIs,
CCBs), anticoagulants (aspirin),
antiarrhythmic (beta blockers and
digoxin), and antihyperlipidemics
(statins)
III- Studies describing adverse drug events (n = 3)
Al-Tajir and
Kelly (2005)
United
Arab
Emirates
Prospective cohort
study
Definition for ADE according
to WHO (WHO, 1999)
The incidence of ADE was
detected through
spontaneous reporting the
first and last quarter of the
year 2003. During the second
and third quarters, active
monitoring for ADEs took
place. ADEs were identified
by looking for the
documented events and by
using an ADE trigger list
(Used by Gandhi et al., 2001)
ADEs were assessed for
causality using the Naranjo
algorithm (Naranjo et al.,
1981) and for severity and
preventability
The incidence of ADEs was
calculated and the two
different detection methods
were compared
The incidence of ADEs detected
through surveillance was
significantly higher (P < 0.001)
than for ADEs reported
spontaneously for both inpatients
(and outpatients. Most ADEs were
judged to be of mild to moderate
severity. Approx. 56% of ADEs
were judged definite or probable
and, of these, approx. 14% were
consistently judged preventable.
The most prevalent drugs
implicated were central nervous
system, antiinfective, and
cardiovascular agents
Aljadhey et al.
(2013)a
Saudi
Arabia
Prospective cohort
study
ADE as per (Jha et al., 1998)
as well as Gandhi et al.
(2000)
A potential ADE as per
(Morimoto et al., 2004)
Incidents were identified
through a combination of
medical record review by
study pharmacists and
voluntary reports from other
Primary outcomes of this
study were the frequency of,
ADEs, potential ADEs and
medication errors
The secondary outcomes
During the study period, there
were 977 admissions with 9585
patient-days in the 5 study units.
Pharmacists identified 361
incidents in 261 patients during
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Medication error and cate-
gory classification as per
Medication Error Reporting
and Prevention (NCC MERP)
(2005) were defined as harm
from medications
healthcare professionals.
Trigger tool was used to
guide chart review further
were the severity of these
events, their preventability
and the associated risk
factors
the study period, of which the
reviewers accepted 281.
Approximately 30% of the
accepted incidents were ADEs,
judged definitely or probably
preventable. Two hundred and
twenty-three incidents were
classified as medication errors, of
which (approximately 59%) had
the potential to cause harm. The
incidence of ADEs in was 8.5 per
100 admissions. Preventable
ADEs most commonly occurred in
the ordering stage
Aljadhey et al.
(2016)
Saudi
Arabia
Prospective cohort
study
Each incident was defined as
an ADE (preventable and
non-preventable), potential
ADE (PADE) (which was
classified as either
intercepted or non-
intercepted), or a medication
error with low risk of
causing harm.
Used definitions adapted
from Bates et al. (1995)a,b
and Morimoto et al. (2004)
and World Health
Organization (2014).
Data collected from four
hospitals (a teaching
hospital, one large and one
small government hospital
and one private hospital),
Incidents were identified
through a combination of
medical record review by
study pharmacists and
voluntary reports from other
healthcare professionals.
Two independent clinicians
were provided with a study
manual guide to
independently review the
incidents and decide on
inclusion of incidents and
further classify them as
ADEs, PADEs or medication
errors with low risk of
causing harm. They were
then able to assess severity
and preventability. This was
a methodology developed by
the Brigham and Women’s
Hospital’s Centre for Patient
Safety Research and Practice
Bates et al. (1995)a
Objective was to estimate
the incidence and risk
factors associated with ADEs
and determine their severity
and preventability. Primary
outcomes were incidence of
ADEs, PADEs and medication
errors with low risk of
causing harm. Secondary
outcomes were severity of
events, their preventability,
and associated risk factors
Complete data for 3985 patients
were analysed. One thousand six
hundred seventy-six cases of
ADEs, PADEs, and medication
errors were identified. Physicians
reviewed and accepted 1531
(approx. 91%). They were
classified as: Approx. 40%
medication errors with low risk of
harm, approx. 44% PADEs, and
approx. 16% ADEs. Of the ADEs,
approx. 35% were deemed
preventable. ‘‘Errors resulting
from preventable ADEs were
most common at the prescribing
stage followed by the dispensing
and administering stages. Most of
the preventable ADEs were
judged to be serious”
IV- Studies assessing interventions of pharmacists (n = 9)
Rahman et al.
(1994)
Saudi
Arabia
Interventional
study
Not stated (it’s an abstract) The pharmacist, after
confirmation with the
physician, documented the
intervention. A computer
Pharmacist intervention,
documentation and problem
resolution of erroneous
physician prescription
The intervention (error rate) was
approx. 1%. Approx. 34% were
dose related while 67% as minor
in terms of severity. Anti-
(continued on next page)
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Appendix D (continued)
Reference Country Design Definitions used for study
outcomes
Method of error
identification
Medication safety aspect
analysed
Reported results
program was developed
using FOXPRO. Interventions
made during the one year
study period were analysed
infectives were involved in
approx. 21%
Al-Jazairi et al.
(2008)
Saudi
Arabia
Prospective, non-
randomised
observational
study
None Stated The clinical pharmacist
performed daily multi-
disciplinary rounds, with
documentation of all
interventions. At the end of
the round the clinical
pharmacist completed a data
collection form to record
each intervention given. A
physician verified all
interventions for validity and
clinical significance
To evaluate the rate, (and
clinical significance,
acceptance by medical team)
of clinical pharmacist’s
interventions in a cardiac
surgery intensive care
setting
The clinical pharmacist made 394
interventions on 600 patients.
The medical team accepted 328
interventions (approx. 83%). Main
drug related problems and
interventions were: no drug
prescribed for the medical
condition, inappropriate dosing
regimen (including dose, rate,
frequency, and route), no
indication for drug use and
inappropriate drug selection.
The anticipated outcome of the
interventions were targeted
enhancing therapeutic outcomes,
resolution/prevention of an
adverse drug reaction or toxicity
and cost saving
Hooper et al.
(2009)
Qatar Prospective,
Interventional
study
1. Definition for a pharmacy
intervention was: Working
definition for intervention:
‘any contact made by a
pharmacist during the
dispensing process with a
prescriber or a patient and
that was aimed at
rationalizing drug
prescribing or use’
Medication errors defined as
per Flynn and Barker (1999)
Drug related problem de-
fined as per PCNE (1999)
3. Considered a prescribing
error as any prescribing
decision which results, or
had the potential to result in,
an unintentional significant
reduction in the probability
of treatment being timely
and effective, or an increase
in the risk of patient harm
Pharmacists used online
integrated health care
software (TrakCare;
InterSystems, Cambridge,
MA, USA) to document all
interventions made. Each
intervention made was
communicated to the
respective prescriber. All
interventions and their
outcomes were reviewed
later by two members from
the research team
Prescribing error
interventions documented
by pharmacists in four
pharmacies in a primary
health care service in Qatar
Of 82,800 patients’ prescriptions,
594 patients’ prescriptions were
intercepted for suspected errors
(approx. 1%)
The total number of DRP-related
interventions made was 890
interventions
Over half of all errors were
related to drug choice problems,
followed by drug safety problems.
Fifty-three percent of all
interventions were accepted.
Interventions as a result of
transcription errors, legality and
formulary issues were eliminated
from this study through the use of
computerised physician order
entry (CPOE)
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Al-Rashdi et al.
(2010)
Oman Prospective
interventional
study
None stated (it’s an abstract) Interventions on electronic
prescriptions over one-year
were evaluated. A standard
data collection form was
used to capture the relevant
data. Clinical relevance was
defined as to whether
efficacy or toxicity was
either improved or reduced.
Clinical relevance was based
on the judgments of at least
two pharmacists
To evaluate the number and
types of pharmacists’
interventions of electronic
prescriptions at a University
Hospital.
Out of 186,353 prescriptions,
454,654 items were dispensed
and 1123 interventions were
recorded. Only 3% of the
interventions were
administrative (absence of
doctor’s signature/ wrong
patient’s card) while 97% clinical.
The clinical interventions were
categorized into drug regimen
and drug choice. Approx. 62% of
problems associated with drug
regimen were related to wrong
doses. Interventions improved
efficacy and avoided toxicity
Al-Ghamdi
et al. (2012)
Saudi
Arabia.
Prospective,
nonrandomised
observational
study
An ADE was defined as per
(Nebeker et al., 2004) ADEs
due to medication errors
were considered to be pre-
ventable, while those caused
by adverse drug reactions
(without an error) were
considered to be non-
preventable. The incidences
of ADEs after discharge from
the hospital were identified
using a questionnaire
The intervention pharmacist
comprehensively counselled
patients about their
discharge medications. The
control group included
similar patients who
received routine discharge
counselling by nurses. Two
weeks after discharge, the
same pharmacist called the
patients and assessed the
frequency of ADEs. Two
independent clinicians
reviewed each ADEs and
judged its severity and
preventability
To assess a program
involving comprehensive
medication counselling
provided by pharmacists at
the time of discharge. The
study outcome was the
incidence of patient-
reported ADEs after
discharge
Two hundred patients were
included, 100 in the control group
and 100 in the intervention
group. Approx. 88% (175/200)
patients were successfully
contacted two weeks after. ADEs
occurred in 2 patients in the
intervention group and in 21
patients (23 incidents in 21
patients) in the control group (P <
.001). 14 ADEs were judged as
preventable, and 9 were judged as
serious. Warfarin, insulin, anti-
laxatives and iron supplements
were some of the agents involved
Rashed et al.
(2012)
Saudi
Arabia
A prospective
cohort study
Drug-related problems (DRP)
defined as per (PCNE)
Pharmaceutical Care
Network Europe, (2008)
Adopted the data collection
method of intensive chart
review, used by Ghaleb et al.
(2010) and by Dean et al.
(2002). For measurement of
the severity of the DRPs used
validated scale for medica-
tion errors published by
Dean and Barber (1999).
Data were collected using a
modified version of the DRP
Registration Form version
5.01 designed by (PCNE)
Of interest was the
epidemiology of and
potential associated risk
factors of drug-related
problems in hospitalised
children. Once a potential
DRP was identified, causes,
intervention, and outcome of
the intervention were
identified and recorded.
Total paediatric patients were
364, from medical ward, neonatal
intensive care unit and paediatric
intensive care unit
Total No. of DRPs 258; most
common types identified:
Dosing problems made up
approx. 71% of the problems, drug
choice problems approx. 11%, and
adverse drug reactions approx.
6%, with other problem types
making up approx. 12%
The majority of DRPs were
preventable and interventions
mostly made at prescriber level
(continued on next page)
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Appendix D (continued)
Reference Country Design Definitions used for study
outcomes
Method of error
identification
Medication safety aspect
analysed
Reported results
Kheir et al.
(2014)
Qatar Cross-sectional,
descriptive and
exploratory study
The authors adopted the
PCNE’s definition of a DRP
(PCNE) Pharmaceutical Care
Network Europe (2008)
Data generated via semi-
private interviews was
documented
A medication use review
form was adapted from the
form developed by one of the
United Kingdom’s National
Health Services (NHS)
primary care trusts Cumbria.
(NHS, 2011)
The primary outcome
measure for this preliminary
study was characterising the
drug related problems
(DRPs) (types and number)
captured by the pharmacists
during the medication use
reviews
Fifty-two eligible patients were
reviewed by six pharmacists
A total of 175 DRPs were
identified with an average of
approx. 3 DRPs per patient
The most common DRPs reported
were: non-adherence to drug
therapy (approx. 31%), need for
education and counselling
(approx. 23%), and adverse drug
reactions (approx. 21%). There
was a strong association between
the incidence of DRPs and the
patients’ age; as the age increases,
the number of DRPs consistently
increases. As medications
increased, the number of
identified DRPs increased (P 
0.05)
Al Rahbi et al.,
(2014)
Oman Systematic
Retrospective
Study
Not specified and referenced The interventions filed by
pharmacists and assistant
pharmacists in outpatient
pharmacy department were
collected, categorized and
analysed after a detailed
review
The primary objective was to
determine the number and
types of medication errors
intervened by the dispensing
pharmacists at outpatient
pharmacy department. The
study period was one year
Thirty thousand five hundred
sixty-three prescriptions
dispensed. The number of
interventions collected in this
period was 692 interventions,
approx. 2% of the prescriptions.
Approx. 99% of all interventions
were prescribing errors, Ninety-
eight percent were accepted by
prescribers. Approx. 15% of the
interventions were
administrative
Mitwally et al.,
(2015)
Qatar Pre and post-
interventional
analysis of
prescriptions
None stated (abstract) Random prescriptions were
collected for 1 week both
prior and after the
educational phase. The use
of unapproved
abbreviations, trade names,
and the absence/incorrect
patient label was also
considered as a prescribing
error
Investigate whether
physician education had an
impact on reducing
prescribing errors within
inpatient setting. The
intervention consisted of the
clinical pharmacy team
preparing educational
sessions discussing
prescribing errors. The
educational material
included real case scenarios
and the institution’s
prescribing policies
The overall physician attendance
for the educational session was
92 from a total of 102 (approx.
90%)
A total of 1822 prescriptions were
involved in the study, with 948 in
the pre sample and 874 in the
post sample. The total number of
errors within the pre sample was
(approx. 20%) in comparison to
(approx. 10%) errors for the post
sample, an overall reduction of
52% in prescribing errors (P <
0.001)
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V- Perceptions of HCP on ME and ME reporting (n = 3)
Al-Rowibah
and Younis
(2013)
Saudi
Arabia
Cross-sectional
questionnaire
None stated Not applicable To determine whether CPOE
improves the quality of care
by increasing patient safety
and decreasing medication
errors at study setting
The response rate was 31%, with
93 physicians participating. Up to
88% of the physicians agreed that
the use of CPOE improved their
performance and 76% reported
that the use of CPOE increased
their productivity. In addition,
64% reported that it was easy to
use. Fifty-five percent reported
that it created new types of
errors. However, 72% of the
physicians agreed that CPOE
helped them to decrease adverse
drug events and 91% of the
physicians agreed that CPOE
reduced errors related to hand-
written prescriptions
Al-Arifi (2014) Saudi
Arabia
A cross sectional
survey
Dispensing errors defined as
per Szeinbach et al. (2007)
Not applicable To survey pharmacists’
attitudes toward dispensing
errors and factors
contributing to these errors
in community pharmacy
settings
Response rate approx. 82%
Seventeen factors were identified
as contributing to errors, some
are: pharmacist assistant, high
workload, lack of time, and
similar or confusing drug names.
Among the major factors believed
to reduce dispensing errors were
improving doctors’ handwriting,
reducing pharmacist work load,
having drug names that are
distinctive, privacy when
counselling patients, having
mechanism for checking
dispensing procedure, keeping
drug knowledge up to date
Al Anazi and
Al-Jeraisy
(2015)
Saudi
Arabia
Cross-sectional
study conducted A
self-administered
paper based
surveys was used
Not Stated Not applicable The perceptions of
healthcare professionals
with respect to the
underlying factors of
medication errors.
Response rate was 82%. The study
cohort made up of approx. 42%
pharmacists, approx. 31%
physicians, and approx. 27%
nurses. The perceptions of the
professionals on the causes of
errors differed on the following:
interruptions while writing the
order, clarity of physician’s order
and knowledge of allergies
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